At OrganoBiotech, our mission is to accelerate drug discovery by combining human-relevant, high-throughput Organ-on-a-Chip technology with the analytical power of machine learning.
A Collection of OrganoAssay Tissue and Disease Models to Choose From
Vascular Research
Vascular Inflammation
Vascular Fibrosis
Drug-Induced Vascular Toxicity
Respiratory Research
Pulmonary Viral Infections
Asthma Management
Pulmonary Fibrosis
Development in Progress
Gastrointestinal Research
Inflammatory Bowel Disease
Renel Research
Renal Drug Toxicity Evaluation
Renal Fibrosis
Kidney Reperfusion Injury Mechanisms
Reproductive Health Research
Drug Transport Across the Placenta
Preeclampsia Pathophysiology in the Placenta
Development in Progress)
Vascular Research
The Tumor Immune Microenvironment
Our Technology At A Glance
OrganoPlatform
Our core technology is the OrganoPlatforms that enable the development of diverse tissue models and assays. The platform supports tissue-specific customization for various biological systems and provides a scalable 3D perfusion tissue culture environment integrated with sensors ideal for high-throughput screening in drug discovery and biomedical research applications.
OrganoAssay
We have also developed a wide range of functional OrganoAssays on the OrganoPlatform to study complex, progressive, and multifactorial diseases. Traditional cell cultures and animal models often fall short in replicating the intricacies of these chronic conditions. Our assays help bridge this gap by leveraging the cellular diversity of human organoids and dynamic control of organ-on-a-chip systems to mimic the native human tissue environment. This enables reliable preclinical testing of drugs, producing data that truly reflect human physiological responses.
OrganoDrug
Leveraging the OrganoPlatform, we have further incorporated machine learning with high-throughput organ-on-a-chip technology to accelerate the development of OrganoDrugs.
Traditionally, this process from discovery to validation takes extensive time and substantial investment. Our interdisciplinary approach has the potential to achieve these milestones at a faster speed and a reduced cost.
Complete solution to your 3D tissue and organoid culture needs
We offer a suite of platforms and equipment for 3D tissue and organoid culture. These tools are designed to empower researchers to become effective model developers. If you’ve worked with standard multi-well plates, our systems will feel intuitive—yet far more advanced.
Follow us on LinkedIn to see what is new!
We are thrilled about the opportunity to assist Merck 3D Technologies team as they establish their BioFabrication lab! Our co-founder, Dawn Song Yi Lin, has been working closely with Yufang He, Richard Y. Cheng, Narendra Kumar Singh and the team to establish an automated assay workflow with our IFlowPlate and AngioPlate products.
Our Client Support Network
Contact us to discover how OrganoBiotech can support your next breakthrough in organ-on-a-chip innovation.
Press Release
Stay up-to-date with OrganoBiotech’s latest announcements, innovations, reports, info, and company news.
Publications
Explore peer-reviewed research and scientific studies that highlight our technologies and our discoveries.
Protocols
Access detailed step-by-step guides to support reproducible results with OrganoBioTech products and technology.
Posters
Browse visual summaries of key research findings and scientific presentations from previous conferences and events.
